Triphosphate

• Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue.

DIRECTIONS Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water

Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children.

1. 1Off Label Use415%
2. 2Pneumonia415%
3. 3Diarrhoea312%
4. 4Acute Kidney Injury27.7%
5. 5Asthenia27.7%
6. 6Atrial Fibrillation27.7%
7. 7Blood Culture Positive27.7%
8. 8Hypocalcaemia27.7%
9. 9Hyponatraemia27.7%
10. 10Neuromyopathy27.7%
11. 11Pain In Extremity27.7%
12. 12Pancytopenia27.7%
13. 13Rash27.7%
14. 14Systemic Candida27.7%
15. 15Acute Hepatic Failure13.8%

The 10 most recently updated of 157 ClinicalTrials.gov registrations naming Triphosphate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• RegoNivo vs Standard of Care Chemotherapy in AGOC
  Completed · Phase 3 · Interventional · 462 enrolled · Australasian Gastro-Intestinal Trials Group
  NCT04879368updated 2026-06-10
• Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
  Recruiting · Observational · 800 enrolled · National Heart, Lung, and Blood Institute (NHLBI)
  NCT03685721updated 2026-06-08
• Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
  Recruiting · Phase 1 · Interventional · 118 enrolled · Adlai Nortye Biopharma Co., Ltd.
  NCT07252479updated 2026-06-08
• Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
  Recruiting · Phase 3 · Interventional · 200 enrolled · University of Utah
  NCT06112990updated 2026-06-03
• TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
  Active not recruiting · Phase 2 · Interventional · 69 enrolled · St. Jude Children's Research Hospital
  NCT03849651updated 2026-06-03
• Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
  Recruiting · Phase 1 · Interventional · 60 enrolled · St. Jude Children's Research Hospital
  NCT04881240updated 2026-05-26
• CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
  Recruiting · Phase 1 · Interventional · 108 enrolled · St. Jude Children's Research Hospital
  NCT04318678updated 2026-05-19
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  Recruiting · Phase 1 · Interventional · 48 enrolled · St. Jude Children's Research Hospital
  NCT04897321updated 2026-05-19
• Cord Blood Transplantation in Children and Young Adults With Blood Cancer
  Recruiting · Phase 2 · Interventional · 71 enrolled · Memorial Sloan Kettering Cancer Center
  NCT07566377updated 2026-05-14
• Effectiveness of Audio-Tactile Performance Technique With Sing-Along Lyrics on Oral Hygiene Instruction to Visually Impaired Individuals: A Matched-Pair Randomized Study
  Completed · Interventional · 40 enrolled · Mahidol University
  NCT07585448updated 2026-05-13

Frequently asked questions

What is Triphosphate used for?

According to FDA labeling, Triphosphate carries indications including: Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.